
==== Front
Egypt Heart J
Egypt Heart J
The Egyptian Heart Journal
1110-2608
2090-911X
Springer Berlin Heidelberg Berlin/Heidelberg

39230761
549
10.1186/s43044-024-00549-4
Case Report
When the heart and hands tell a story: an intriguing case of Holt–Oram syndrome
http://orcid.org/0009-0002-8319-325X
Atlas Ilyas atlasilyas@gmail.com

Zagdan Soukaina
Megzari Mohamed
Arous Salim
Drighil Abdenasser
grid.414346.0 0000 0004 0647 7037 Cardiology Department, Ibn Rochd Hospital University, Casablanca, Morocco
2 9 2024
2 9 2024
12 2024
76 11721 6 2024
24 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

Holt–Oram syndrome is a rare genetic disorder caused by a mutation in the TBX5 gene, combining skeletal and cardiac malformations. Vital prognosis depends essentially on cardiac involvement, while skeletal malformations determine functional prognosis.

Case presentation

We describe the case of a young patient aged 49, with no particular history, who presented to the emergency department with de novo congestive heart failure. Clinical examination revealed not only signs of heart failure, but also malformations such as triphalangia of the left thumb, prono-supination defects of both forearms and dorsolumbar scoliosis. The electrocardiogram showed that an atypical atrial flutter and transthoracic echocardiography revealed an atrial septal defect. We also performed a spinal scan to assess the severity of the scoliosis. Genetic studies confirmed a TBX5 gene mutation in the patient, and family screening revealed no similar cases in the family. Management consisted mainly of pharmacological treatment of heart failure, in addition to scoliosis management.

Conclusion

Holt–Oram syndrome is a rare genetic disorder which should be suspected in the presence of any upper limb anomaly associated with cardiac malformation and confirmed by genetic study. A family investigation is necessary after diagnosis, because of autosomal dominant inheritance.

Keywords

Holt–Oram syndrome
Genetic disorder
TBX5 gene
issue-copyright-statement© Egyptian Society of Cardiology 2024
==== Body
pmcBackground

Holt–Oram syndrome is a rare genetic disorder that usually associates malformations of one or both upper limbs with congenital heart defects, as well as rhythm and/or conduction disorders requiring pacemaker implantation in certain situations [1]. This pathology is often due to an alteration in the sequence of the TBX5 gene located on chromosome 12 with an autosomal dominant mode of transmission [2]. During early cardiac development, TBX5 shows up to act basically as a transcriptional activator of qualities related to cardiomyocyte development and upstream of morphological signals for septation. In cardiac advancement, TBX5 is required for designing of the cardiac conduction framework and support of develop cardiomyocyte work [3]. Therefore, TBX5 gene mutation is often responsible of atrial or ventricular septal defects observed in Holt–Oram syndrome.

Our aim is to report the clinical, radiological, and genetic findings of this case in order to clarify the attitude to adopt toward this kind of patients.

Case presentation

We describe a 49-year-old male patient, with no particular personal or family history, admitted to the cardiology department for acute rest dyspnea with ongoing palpitations. On admission, the patient was conscious 15/15, apyretic, normotensive to 124/91 and normocardial to 84 bpm, with a saturation of 96% on free air.

Physical examination found some clinical heart failure signs such as bilateral, symmetrical, soft edema of the lower limbs, taking the bucket at pressure and reaching mid-leg, there was also turgidity of the jugular veins with slight abdominal distention, indicating ascites. All these signs of right heart failure were associated with bilateral crepitating rales at the bases when auscultating the lung fields.

Cardiac auscultation revealed a systolic murmur localized at the pulmonary focus (upper left of the sternum) and a doubling of the second heart sound (B2), testifying to increased flow through the pulmonary valve.

Clinical examination also revealed a triphalangeal (Fig. 1) left thumb (red arrow), with the thumbs unable to oppose to other fingers, and a prono-supination defect affecting both forearms (Fig. 2).Fig. 1 Photo of the patient's hands showing triphalangeal left thumb (red arrow)

Fig. 2 Photo showing the lack of prono-supination in the two forearms

In view of this clinical anomaly, X-rays of both hands were taken (Fig. 3), confirming the triphalangeal left thumb (red arrow).Fig. 3 Hand X-rays confirming a triphalangeal left thumb (rogue arrow)

The ECG (Fig. 4) of our patient on admission showed an atypical 3/1 conduction atrial flutter at 84 bpm with ventricular extrasystoles.Fig. 4 Patient's ECG showing atypical flutter

Transthoracic echocardiography (Fig. 5) revealed a left ventricle dilated to 33 mm/m2, with global hypokinesis, some trabeculations and an LVEF calculated at 40% by Simpson biplane. There was also an 18-mm ostium secondum interatrial communication and a left–right shunt (red arrows). The right cavities were extremely dilated, with a spider-webbed right ventricle, in longitudinal systolic dysfunction (TAPSE = 10 mm). The inferior vena cava was dilated to 26 mm and non-compliant, with pulmonary pressures estimated at 52 mmHg, in addition to minimal pericardial effusion. There was no significant mitroaortic valve disease, and the aorta was of normal caliber in the explored segments.Fig. 5 Transthoracic echocardiography showing interatrial communication ostium secondum (red arrows)

In view of these anatomical anomalies and the presence of a spinal deformity, we ordered a thoracic X-ray, which showed scoliosis, and then supplemented this with a spinal CT scan with reconstruction (Fig. 6), confirming dorsolumbar scoliosis.Fig. 6 Spinal scan reconstruction confirming dorsolumbar scoliosis

An abdominal ultrasound was performed to look for associated visceral malformations but came back with no abnormalities.

A genetic consultation was requested, and a genetic study was carried out, which revealed a mutation in the TBX5 gene, confirming Holt–Oram syndrome. Given that this syndrome is inherited in an autosomal dominant fashion, we carried out a family survey in search of similar cases, which proved negative.

Therapeutically, our patient was started on Furosemide injection for decongestion, in addition to potassium supplementation to prevent hypokalemia, with the addition of Ramipril 5 mg/day, Spironolactone 50 mg/day, followed by Bisoprolol 5 mg/day as a beta-blocker after decongestion and Dapagliflozin 10 mg/day. The evolution was marked by the patient's decongestion under intravenous diuretic treatment and then switch to oral treatment, slowing of the flutter under beta-blocker, and clear regression of dyspnea and palpitations under medical treatment.

For the LV dysfunction, a coronary angiography was carried out, revealing a normal, healthy coronary artery free of any significant lesion. In order to identify the cause of this LV dysfunction, a cardiac MRI was requested, but the patient did not have the means to have it done, given the unavailability of this technique in our public hospital.

For his scoliosis, the patient was referred to orthopedic surgery for specialized management. The patient was assessed by orthopedic surgeons, the decision was to schedule surgery for his scoliosis after stabilization of his heart condition and optimization of his heart failure treatment, a surgery that he refused.

As for his ASD, the patient refused all invasive procedures, whether right heart catheterization or percutaneous closure, and choose to stay under medical treatment alone.

The patient was then followed up in consultation for 6 months, once a week for the 1st month, twice a month for 2 months and then once every month for 3 months and until now, without any decompensation episode or rehospitalization, and with a clear improvement in quality of life on medical treatment alone, since he refused every other invasive therapy, neither for the ASD nor for the scoliosis.

Discussion

Holt–Oram syndrome was first described in 1960 by Holt and Oram at King College Hospital in London [4]. The syndrome is very rare, autosomal dominant, with an incidence of around 0.95 per 100,000 births, with no predilection for either male or female sex [5].

The characteristics of this syndrome are anomalies of one or both upper limbs, with, more rarely, anomalies of the shoulder girdle, and often congenital cardiac malformations. The typical combination is considered to be a triphalangeal thumb with an intra-auricular communication secondum, but the severity of the cardiac and skeletal lesions can be highly variable and condition the prognosis [6].

The most frequent cardiac malformations are septal interatrial and/or interventricular septal defects, coarctation of the aorta with or without aortic bicuspidism, mitral valve anomalies, patent ductus arteriosus, conduction, and/or rhythm disorders [7]. Skeletal malformations of the upper limbs include thumb anomalies (absence or hypoplasia, triphalangia or syndactyly), agenesis or hypoplasia of the radius, ulna, or even humerus. Hypoplasia of the clavicles and anomalies of the thorax and/or spine may also be observed [8]. Our patient presents with a triphalangeal left thumb, fairly important dorsolumbar scoliosis, interatrial communication ostium secondum and an atrial flutter, in line with the literature and the historical description of this syndrome.

Vanlerberghe et al. [9] reported in their work that there are several genetic variants of this syndrome, also due to mutation of the TBX5 gene but with some variations on the molecular level, and manifested by other anomalies such as "pectus excavatum", pulmonary agenesis, Tetralogy of Fallot, or cardiomyopathy without septal defect.

According to the literature, these variants can be explained by the involvement of TBX5 in the development of the sternum and lung too and may be due to incomplete penetrance of this mutation [10–12].

The main differential diagnoses of SOH described by Vanlerberghe et al. [9] are Okihiro syndrome, Fanconi anemia, and TAR syndrome. For our patient, Holt and Oram syndrome was confirmed due to the presence of the TBX5 gene mutation, which allowed other differential diagnoses of this syndrome to be ruled out.

Silengo et al. [13] in turn described the Heart-Main syndrome type II or Tabatznik syndrome associating brachydactyly type D with supraventricular tachycardia, Ruiz de La Fuente and Prieto [14] described the Heart-Main Syndrome type III associating brachydactyly type C with sick sinus syndrome, while Hollister described the Long Thumb-Brachydactyly Syndrome [15]. Thus, there are many differential diagnoses of SOH and some may present similar clinical abnormalities, and the difference between all these different syndromes can only be made by genetic study.

In the absence of specific treatment for this condition, we resorted to the treatment of heart failure with reduced LVEF, including diuretics in case of congestive signs, a beta-blocker (Bisoprolol) for his arrhythmia and for the heart failure, an anti-mineralocorticoid (Spironolactone) and an SGLT2 inhibitor, based on the recommendations of the European Society of Cardiology for the management of heart failure [16]. This is just one case report, limited essentially by the number of patients, which is reduced to 1, and by the very limited financial resources available in a middle-income country.

Conclusion

Holt–Oram syndrome is a rare genetic disorder that can have a number of clinical implications, including skeletal malformations affecting mainly the upper limbs in association with congenital heart defects, which in certain situations can be life-threatening. The syndrome should be suspected in the presence of any upper limb anomaly associated with a congenital heart defect and confirmed by genetic study. Once the diagnosis has been confirmed, a family investigation is required, given the autosomal dominant mode of transmission. To date, there is no specific treatment for this condition, and management will essentially be based on the treatment of skeletal malformations if indicated, and on the management of any cardiac pathologies expressed. With reference to our case report, we understand that every patient must be seen, assessed and examined as a whole, and that certain cardiac malformations, although frequent, may in certain situations fall into the category of rare syndromic diseases that require the most comprehensive patient management possible.

Abbreviations

TBX5 T-box transcription factor 5

BPM Beat per minute

ECG Electrocardiogram

ASD Atrial septal defect

LVEF Left ventricle ejection fraction

TAPSE Tricuspid annulus plane systolic excursion

CT Computed tomography

TAR Thrombocytopenia absent radius

SGLT2 Sodium–glucose cotransporter 2 inhibitor

LV Left ventricle

Acknowledgements

Not applicable.

Author contributions

AI and ZS were involved in patient care, review of the literature, and writing the case. MM was involved in writing the case. SA and DA were involved in discussing and reviewing the case.

Funding

No funding to declare.

Availability of data and materials

All data and material to this report are accessible at any time upon request.

Declarations

Ethics approval and consent to participate

As international standard, written ethical approval has been collected and preserved by the authors.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Competing interests

The authors declare that they have no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Skwarek-Dziekanowska A Wójtowicz-Ściślak A Sobieszek G Holt–Oram syndrome Eur Rev Med Pharmacol Sci 2024 28 1 336 341 10.26355/eurrev_202401_34921 38235884
Skwarek-Dziekanowska A, Wójtowicz-Ściślak A, Sobieszek G (2024) Holt–Oram syndrome. Eur Rev Med Pharmacol Sci 28(1):336–341. 10.26355/eurrev_202401_3492138235884 10.26355/eurrev_202401_34921
2. Krauser A, Ponnarasu S, Schury M (2021) Holt Oram syndrome. StatPearls [Internet]
3. Steimle JD Moskowitz IP TBX5: a key regulator of heart development Curr Top Dev Biol 2017 122 195 221 10.1016/bs.ctdb.2016.08.008 28057264
Steimle JD, Moskowitz IP (2017) TBX5: a key regulator of heart development. Curr Top Dev Biol 122:195–221. 10.1016/bs.ctdb.2016.08.00828057264 10.1016/bs.ctdb.2016.08.008
4. Holt M Oram S Familial heart disease with skeletal malformations Br Heart J 1960 22 236 242 10.1136/hrt.22.2.236 14402857
Holt M, Oram S (1960) Familial heart disease with skeletal malformations. Br Heart J 22:236–24214402857 10.1136/hrt.22.2.236
5. Arkoumanis PT Gklavas A Karageorgou M Gourzi P Mantzaris G Pantou M Papaconstantinou I Holt–Oram syndrome in a patient with Crohn’s disease: a rare case report and literature review Med Arch 2018 72 292 294 10.5455/medarh.2018.72.292-294 30514998
Arkoumanis PT, Gklavas A, Karageorgou M, Gourzi P, Mantzaris G, Pantou M, Papaconstantinou I (2018) Holt–Oram syndrome in a patient with Crohn’s disease: a rare case report and literature review. Med Arch 72:292–29430514998 10.5455/medarh.2018.72.292-294
6. Hurst JA Hall CM Baraitser M The Holt–Oram syndrome J Med Genet 1991 28 6 406 410 10.1136/jmg.28.6.406 1870097
Hurst JA, Hall CM, Baraitser M (1991) The Holt–Oram syndrome. J Med Genet 28(6):406–410. 10.1136/jmg.28.6.4061870097 10.1136/jmg.28.6.406
7. Vanlerberghe C Jourdain AS Ghoumid J Holt–Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants Eur J Hum Genet 2019 27 3 360 368 10.1038/s41431-018-0303-3 30552424
Vanlerberghe C, Jourdain AS, Ghoumid J et al (2019) Holt–Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants. Eur J Hum Genet 27(3):360–368. 10.1038/s41431-018-0303-330552424 10.1038/s41431-018-0303-3
8. Tyczyński P Michałowska I Miłosz-Wieczorek B Hoffman P Witkowski A Holt–Oram syndrome, bicuspid aortic valve, and patent ductus arteriosus Kardiol Pol 2021 79 12 1395 1396 10.33963/KP.a2021.0118 34599494
Tyczyński P, Michałowska I, Miłosz-Wieczorek B, Hoffman P, Witkowski A (2021) Holt–Oram syndrome, bicuspid aortic valve, and patent ductus arteriosus. Kardiol Pol 79(12):1395–1396. 10.33963/KP.a2021.011834599494 10.33963/KP.a2021.0118
9. Vanlerberghe C Jourdain AS Ghoumid J Frenois F Mezel A Vaksmann G Lenne B Delobel B Porchet N Cormier-Daire V Smol T Escande F Manouvrier-Hanu S Petit F Holt–Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants Eur J Hum Genet 2019 27 3 360 368 10.1038/s41431-018-0303-3 30552424
Vanlerberghe C, Jourdain AS, Ghoumid J, Frenois F, Mezel A, Vaksmann G, Lenne B, Delobel B, Porchet N, Cormier-Daire V, Smol T, Escande F, Manouvrier-Hanu S, Petit F (2019) Holt–Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants. Eur J Hum Genet 27(3):360–368. 10.1038/s41431-018-0303-330552424 10.1038/s41431-018-0303-3
10. Tseng YR Su YN Lu FL Holt–Oram syndrome with right lung agenesis caused by a de novo mutation in the TBX5 gene Am J Med Genet A 2007 143A 1012 1014 10.1002/ajmg.a.31672 17366586
Tseng YR, Su YN, Lu FL et al (2007) Holt–Oram syndrome with right lung agenesis caused by a de novo mutation in the TBX5 gene. Am J Med Genet A 143A:1012–1014. 10.1002/ajmg.a.3167217366586 10.1002/ajmg.a.31672
11. Brassington AME Sung SS Toydemir RM Expressivity of Holt–Oram syndrome is not predicted by TBX5 genotype Am J Hum Genet 2003 73 74 85 10.1086/376436.[PMCfreearticle][PubMed][CrossRef][GoogleScholar][Reflist] 12789647
Brassington AME, Sung SS, Toydemir RM et al (2003) Expressivity of Holt–Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet 73:74–85. 10.1086/376436.[PMCfreearticle][PubMed][CrossRef][GoogleScholar][Reflist]12789647 10.1086/376436.[PMCfreearticle][PubMed][CrossRef][GoogleScholar][Reflist]
12. Boogerd CJJ Dooijes D Ilgun A Functional analysis of novel TBX5 T-box mutations associated with Holt–Oram syndrome Cardiovasc Res 2010 88 130 139 10.1093/cvr/cvq178.[PubMed][CrossRef][GoogleScholar][Reflist] 20519243
Boogerd CJJ, Dooijes D, Ilgun A et al (2010) Functional analysis of novel TBX5 T-box mutations associated with Holt–Oram syndrome. Cardiovasc Res 88:130–139. 10.1093/cvr/cvq178.[PubMed][CrossRef][GoogleScholar][Reflist]20519243 10.1093/cvr/cvq178.[PubMed][CrossRef][GoogleScholar][Reflist]
13. Silengo MC Biagioli M Guala A Lopez-Bell G Lala R Heart-hand syndrome I. A report of Tabatznik syndrome with new findings Clin Genet 1990 38 105 113 10.1111/j.1399-0004.1990.tb03556.x 1976459
Silengo MC, Biagioli M, Guala A, Lopez-Bell G, Lala R (1990) Heart-hand syndrome I. A report of Tabatznik syndrome with new findings. Clin Genet 38:105–1131976459 10.1111/j.1399-0004.1990.tb03556.x
14. Ruiz De La Fuente S Prieto F Heart-hand syndrome I. A new syndrome in three generations Hum Genet 1980 55 43 47 10.1007/BF00329125 7450756
Ruiz De La Fuente S, Prieto F (1980) Heart-hand syndrome I. A new syndrome in three generations. Hum Genet 55:43–477450756 10.1007/BF00329125
15. Hollister DW Hollister WG The "long thumb" brachydactyly syndrome Am J Med Genet 1981 8 5 16 10.1002/ajmg.1320080103 7246605
Hollister DW, Hollister WG (1981) The “long thumb” brachydactyly syndrome. Am J Med Genet 8:5–167246605 10.1002/ajmg.1320080103
16. McDonagh TA Metra M Adamo M Gardner RS Baumbach A Böhm M Burri H Butler J Čelutkienė J Chioncel O Cleland JG Crespo-Leiro MG Farmakis D Gilard M Heymans S Hoes AW Jaarsma T Jankowska EA Lainscak M Lam CSP Lyon AR McMurray JJV Mebazaa A Mindham R Muneretto C Francesco Piepoli M Price S Rosano GMC Ruschitzka F Skibelund AK ESC Scientific Document Group 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC Eur Heart J 2023 44 37 3627 3639 10.1093/eurheartj/ehad195 37622666
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group (2023) 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 44(37):3627–3639. 10.1093/eurheartj/ehad19537622666 10.1093/eurheartj/ehad195
